Your browser doesn't support javascript.
Rational medication in clinical practice for COVID-19 guided by Shanghai expert consensus. TT -, --"".
Chinese Journal of Clinical Infectious Diseases ; 14(1):7-12, 2021.
Article in Chinese | EMBASE | ID: covidwho-2306475
ABSTRACT
The outbreak of COVID-19 occurred in January 2020, the epidemic is still rampant around the world. The Shanghai Expert Consensus on Comprehensive Treatment and Management of Corona Virus Disease 2019 was issued in early March 2020, which provided the guidance of the standardized treatment and rational medication for COVID-19. The administration of " four agents (glucocorticoids, heparin, high-dose vitamin C, Interferon-kappa) and one peptide (thymic peptide)" recommended by the consensus is the key to successfully block and treat critical illness.Copyright © 2021 Chinese Medical Association
Keywords

Full text: Available Collection: Databases of international organizations Database: EMBASE Type of study: Prognostic study Language: Chinese Journal: Chinese Journal of Clinical Infectious Diseases Year: 2021 Document Type: Article

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: Databases of international organizations Database: EMBASE Type of study: Prognostic study Language: Chinese Journal: Chinese Journal of Clinical Infectious Diseases Year: 2021 Document Type: Article